Literature DB >> 2230987

Nonuniformity in myocardial accumulation of fluorine-18-fluorodeoxyglucose in normal fasted humans.

R J Gropler1, B A Siegel, K J Lee, S M Moerlein, D J Perry, S R Bergmann, E M Geltman.   

Abstract

In initial studies using fluorine-18-fluorodeoxyglucose (FDG) in normal fasted subjects, we observed disparities in the regional myocardial accumulation of this tracer. Accordingly, we systematically evaluated regional myocardial FDG accumulation in comparison with regional myocardial perfusion assessed with oxygen-15-water and oxidative metabolism assessed with carbon-11-acetate in nine normal subjects (four studied after a 5-hr fast and five studied both fasted and following glucose loading). Under fasting conditions, myocardial accumulation of FDG in the septum and anterior wall averaged 80% of that in the lateral and posterior walls (p less than 0.03). In contrast, after glucose loading the regional distribution of myocardial FDG accumulation became more homogeneous. Regional myocardial perfusion, oxidative metabolism, and accumulation of carbon-11-acetate were homogeneous under both conditions. Thus, under fasting conditions there are regional variations in myocardial accumulation of FDG, which are visually apparent, are not associated with concomitant changes in oxidative metabolism or perfusion, and cannot be attributed to partial-volume effects. This significant heterogeneity may limit the specificity of PET with FDG for detecting myocardial ischemia in fasting subjects.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2230987

Source DB:  PubMed          Journal:  J Nucl Med        ISSN: 0161-5505            Impact factor:   10.057


  59 in total

Review 1.  Imaging myocardial metabolic remodeling.

Authors:  Robert J Gropler; Rob S B Beanlands; Vasken Dilsizian; E Douglas Lewandowski; Flordeliza S Villanueva; Maria Cecilia Ziadi
Journal:  J Nucl Med       Date:  2010-05-01       Impact factor: 10.057

2.  Quantitative fluorine 18 deoxyglucose uptake by myocardial positron emission tomography in rats.

Authors:  Nobuhiro Handa; Yasuhiro Magata; Eiji Tadamura; Takahiro Mukai; Takeshi Nishina; Senri Miwa; Yutaka Sakakibara; Takuya Nomoto; Junji Konishi; Kazunobu Nishimura; Masashi Komeda
Journal:  J Nucl Cardiol       Date:  2002 Nov-Dec       Impact factor: 5.952

3.  Exercise four hour redistribution thallium-201 single photon emission computed tomography and exercise induced ST segment elevation in detecting the viable myocardium in patients with acute myocardial infarction.

Authors:  H Yamagishi; K Akioka; M Takagi; A Tanaka; K Takeuchi; J Yoshikawa; H Ochi
Journal:  Heart       Date:  1999-01       Impact factor: 5.994

4.  Safety and feasibility of cardiac FDG SPECT following oral administration of Acipimox, a nicotinic acid derivative: Comparison of image quality with hyperinsulinemic euglycemic clamping in nondiabetic patients.

Authors:  Jeroen J Bax; Frans C Visser; Don Poldermans; Arthur Van Lingen; Abdou Elhendy; Eric Boersma; Gerrit W Sloof; Cees A Visser
Journal:  J Nucl Cardiol       Date:  2002 Nov-Dec       Impact factor: 5.952

5.  PET myocardial perfusion and glucose metabolism imaging: Part 2-Guidelines for interpretation and reporting.

Authors:  Heinrich R Schelbert; Robert Beanlands; Frank Bengel; Juhani Knuuti; Marcelo Dicarli; Josef Machac; Randolph Patterson
Journal:  J Nucl Cardiol       Date:  2003 Sep-Oct       Impact factor: 5.952

Review 6.  Receptor function reserve: a new parameter for disease detection.

Authors:  H William Strauss
Journal:  Eur J Nucl Med Mol Imaging       Date:  2004-12       Impact factor: 9.236

Review 7.  Hibernation and myocardial ischemia: clinical detection by positron emission tomography.

Authors:  N G Uren; P G Camici
Journal:  Cardiovasc Drugs Ther       Date:  1992-06       Impact factor: 3.727

Review 8.  Uses and limitations of positron emission tomography in clinical pharmacokinetics/dynamics (Part II).

Authors:  L L Ponto; J A Ponto
Journal:  Clin Pharmacokinet       Date:  1992-04       Impact factor: 6.447

Review 9.  Ischaemic memory imaging using metabolic radiopharmaceuticals: overview of clinical settings and ongoing investigations.

Authors:  Keiichiro Yoshinaga; Masanao Naya; Tohru Shiga; Eriko Suzuki; Nagara Tamaki
Journal:  Eur J Nucl Med Mol Imaging       Date:  2013-11-12       Impact factor: 9.236

10.  Factors affecting myocardial 2-[F-18]fluoro-2-deoxy-D-glucose uptake in positron emission tomography studies of normal humans.

Authors:  Y Choi; R C Brunken; R A Hawkins; S C Huang; D B Buxton; C K Hoh; M E Phelps; H R Schelbert
Journal:  Eur J Nucl Med       Date:  1993-04
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.